These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 30019435

  • 1. Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.
    Bremer J, Kramer D, Eichhorn DS, Gostyński A, Diercks GFH, Jonkman MF, van den Akker PC, Pasmooij AMG.
    Exp Dermatol; 2019 Oct; 28(10):1153-1155. PubMed ID: 30019435
    [Abstract] [Full Text] [Related]

  • 2. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.
    Supp DM, Hahn JM, Combs KA, McFarland KL, Schwentker A, Boissy RE, Boyce ST, Powell HM, Lucky AW.
    Cell Transplant; 2019 Oct; 28(9-10):1242-1256. PubMed ID: 31271052
    [Abstract] [Full Text] [Related]

  • 3. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
    Petrova A, Georgiadis C, Fleck RA, Allison L, McGrath JA, Dazzi F, Di WL, Qasim W.
    J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
    [Abstract] [Full Text] [Related]

  • 4. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
    Berthault C, Gaucher S, Gouin O, Schmitt A, Chen M, Woodley D, Titeux M, Hovnanian A, Izmiryan A.
    J Invest Dermatol; 2024 Jun; 144(6):1322-1333.e13. PubMed ID: 38043638
    [Abstract] [Full Text] [Related]

  • 5. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells.
    Matsuda A, Hasegawa T, Ikeda Y, Wada A, Ikeda S.
    J Dermatol Sci; 2024 Jul; 115(1):42-50. PubMed ID: 38876908
    [Abstract] [Full Text] [Related]

  • 6. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
    Remington J, Wang X, Hou Y, Zhou H, Burnett J, Muirhead T, Uitto J, Keene DR, Woodley DT, Chen M.
    Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
    [Abstract] [Full Text] [Related]

  • 7. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
    Goto M, Sawamura D, Ito K, Abe M, Nishie W, Sakai K, Shibaki A, Akiyama M, Shimizu H.
    J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
    [Abstract] [Full Text] [Related]

  • 8. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
    Peking P, Koller U, Duarte B, Murillas R, Wolf S, Maetzig T, Rothe M, Kocher T, García M, Brachtl G, Schambach A, Larcher F, Reichelt J, Bauer JW, Murauer EM.
    Nucleic Acids Res; 2017 Sep 29; 45(17):10259-10269. PubMed ID: 28973459
    [Abstract] [Full Text] [Related]

  • 9. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP.
    JAMA; 2016 Nov 01; 316(17):1808-1817. PubMed ID: 27802546
    [Abstract] [Full Text] [Related]

  • 10. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S, Titeux M, Tonasso L, Décha A, Ishida-Yamamoto A, Hovnanian A.
    J Invest Dermatol; 2016 Dec 01; 136(12):2387-2395. PubMed ID: 27498345
    [Abstract] [Full Text] [Related]

  • 11. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
    Woodley DT, Krueger GG, Jorgensen CM, Fairley JA, Atha T, Huang Y, Chan L, Keene DR, Chen M.
    J Invest Dermatol; 2003 Nov 01; 121(5):1021-8. PubMed ID: 14708601
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Hong SA, Kim SE, Lee AY, Hwang GH, Kim JH, Iwata H, Kim SC, Bae S, Lee SE.
    Mol Ther; 2022 Aug 03; 30(8):2664-2679. PubMed ID: 35690907
    [Abstract] [Full Text] [Related]

  • 13. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M, Kasahara N, Keene DR, Chan L, Hoeffler WK, Finlay D, Barcova M, Cannon PM, Mazurek C, Woodley DT.
    Nat Genet; 2002 Dec 03; 32(4):670-5. PubMed ID: 12426566
    [Abstract] [Full Text] [Related]

  • 14. Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Woodley DT, Hao M, Kwong A, Levian B, Cogan J, Hou Y, Mosallaei D, Kleinman E, Zheng K, Chung C, Kim G, Peng D, Chen M.
    Br J Dermatol; 2024 Jul 16; 191(2):267-274. PubMed ID: 38366625
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
    Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, Xia L, Lund T, Slattery C, Uitto J, Christiano AM, Wagner JE, Blazar BR.
    Blood; 2009 Jan 29; 113(5):1167-74. PubMed ID: 18955559
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
    Liao Y, Ivanova L, Sivalenka R, Plumer T, Zhu H, Zhang X, Christiano AM, McGrath JA, Gurney JP, Cairo MS.
    Stem Cells Transl Med; 2018 Jul 29; 7(7):530-542. PubMed ID: 29745997
    [Abstract] [Full Text] [Related]

  • 17. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
    Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, Elia G, Jeffery R, Leigh IM, Navsaria H, McGrath JA.
    J Invest Dermatol; 2008 Sep 29; 128(9):2179-89. PubMed ID: 18385758
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
    Primerano A, De Domenico E, Cianfarani F, De Luca N, Floriddia G, Teson M, Cristofoletti C, Cardarelli S, Scaglione GL, Baldini E, Cangelosi D, Uva P, Reinoso Sánchez JF, Roubaty C, Dengjel J, Nyström A, Mastroeni S, Ulisse S, Castiglia D, Odorisio T.
    Br J Dermatol; 2024 Sep 18; 191(4):568-579. PubMed ID: 38820176
    [Abstract] [Full Text] [Related]

  • 19. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K, Eide C, Riddle MJ, Xia L, Lees CJ, Chen W, Mathews W, Keene DR, McGrath JA, Tolar J.
    Br J Dermatol; 2019 Dec 18; 181(6):1247-1253. PubMed ID: 30924923
    [Abstract] [Full Text] [Related]

  • 20. Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.
    Georgiadis C, Syed F, Petrova A, Abdul-Wahab A, Lwin SM, Farzaneh F, Chan L, Ghani S, Fleck RA, Glover L, McMillan JR, Chen M, Thrasher AJ, McGrath JA, Di WL, Qasim W.
    J Invest Dermatol; 2016 Jan 18; 136(1):284-92. PubMed ID: 26763448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.